Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qianyangyuyin Formula for Early Renal Injury in Hypertension
NCT04078711Phase 3Unknown
- Sponsor
- Jiangsu Provincial Hospital of Traditional Chinese Medicine
- Start
- Sep 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of qianyangyuyin in acute kidney failure (AKF), sponsored by Jiangsu Provincial Hospital of Traditional Chinese Medicine. Status: unknown.
02
Drugs
qianyangyuyin
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on NCT04078711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04078711.